Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
25.72%Buyback Yield
VS
Market
Sector
Industry
History
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | 25.72% | $ 7M | $ -1.8M |
| 3/31/2025 | 42.71% | $ 5.95M | $ -2.54M |
| 12/31/2024 | 32.69% | $ 10.84M | $ -3.55M |
| 9/30/2024 | 31.05% | $ 11.99M | $ -3.72M |
| 6/30/2024 | 17.2% | $ 14.44M | $ -2.48M |
| 3/31/2024 | 197.7% | $ 14.26M | $ -28.2M |
| 12/31/2023 | 184.13% | $ 17.01M | $ -31.33M |
| 9/30/2023 | 187.36% | $ 18.52M | $ -34.71M |
| 6/30/2023 | 173.52% | $ 21.86M | $ -37.93M |
| 3/31/2023 | 58.07% | $ 23.35M | $ -13.56M |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) Buyback Yield stands at -49.73%.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average Buyback Yield has been 5.19%.
- The median Buyback Yield for PHARMACYTE BIOTECH INC during this period was 17.81%
- PHARMACYTE BIOTECH INC reached its highest Buyback Yield over the past 5 years at 197.7%.
- The lowest Buyback Yield recorded by PHARMACYTE BIOTECH INC in the same timeframe -202.7%
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for PHARMACYTE BIOTECH INC is calculated as follows: (-1 * CF - Equity [ $ 6.48M ]) / Market Cap [ $ 13.03M ]
(=) Buyback Yield [ -49.73% ] PMCB - Buyback Yield, Last 5 years
-202.7%
Minimum
Dec 31, 2021
197.7%
Maximum
Mar 31, 2024
5.19%
Average
17.81%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.43% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |